vinpocetine has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves-Filho, JC; Bernardy, CCF; Borghi, SM; Casagrande, R; Cunha, FQ; Cunha, TM; Domiciano, TP; Fattori, V; Lourenco-Gonzalez, Y; Rossaneis, AC; Verri, WA; Zaninelli, TH | 1 |
| Casagrande, R; Pavão-de-Souza, GF; Pinho-Ribeiro, FA; Ruiz-Miyazawa, KW; Verri, WA; Zarpelon, AC | 1 |
2 other study(ies) available for vinpocetine and Allodynia
| Article | Year |
|---|---|
Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Drug Repositioning; Edema; Heme Oxygenase-1; Hyperalgesia; Inflammation; Male; Membrane Proteins; Mice; NF-E2-Related Factor 2; NF-kappa B; Nootropic Agents; Oxidative Stress; Reactive Oxygen Species; Superoxides; Vinca Alkaloids | 2019 |
Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.
Topics: Animals; Carrageenan; Cytokines; Extremities; Glutathione; Hyperalgesia; Male; Mice; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Spinal Cord; Superoxides; Vinca Alkaloids | 2015 |